6782 — Visco Vision Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual income statement for Visco Vision, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,472	1,526	1,964	2,778	2,398
Cost of Revenue
Gross Profit	632	550	839	1,233	857
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	1,217	1,365	1,558	2,068	2,077
Operating Profit	255	162	406	710	321
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	238	116	404	713	296
Provision for Income Taxes
Net Income After Taxes	316	128	444	614	295
Minority Interest
Net Income Before Extraordinary Items
Net Income	316	128	444	617	302
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	316	128	444	617	302
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.77	2.31	8.08	11.1	4.95
Dividends per Share